Galmed Pharmaceuticals: Q2 Earnings Snapshot

August 4, 2022 GMT

TEL AVIV, Israel (AP) _ Galmed Pharmaceuticals Ltd. (GLMD) on Thursday reported a loss of $3.4 million in its second quarter.

The Tel Aviv, Israel-based company said it had a loss of 15 cents per share.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on GLMD at